Journal Menu
► ▼ Journal Menu-
- Molecules Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Vol. 29 (2024)
- Vol. 28 (2023)
- Vol. 27 (2022)
- Vol. 26 (2021)
- Vol. 25 (2020)
- Vol. 24 (2019)
- Vol. 23 (2018)
- Vol. 22 (2017)
- Vol. 21 (2016)
- Vol. 20 (2015)
- Vol. 19 (2014)
- Vol. 18 (2013)
- Vol. 17 (2012)
- Vol. 16 (2011)
- Vol. 15 (2010)
- Vol. 14 (2009)
- Vol. 13 (2008)
- Vol. 12 (2007)
- Vol. 11 (2006)
- Vol. 10 (2005)
- Vol. 9 (2004)
- Vol. 8 (2003)
- Vol. 7 (2002)
- Vol. 6 (2001)
- Vol. 5 (2000)
- Vol. 4 (1999)
- Vol. 3 (1998)
- Vol. 2 (1997)
- Volumes not published by MDPI
Need Help?
Announcements
6 December 2024
Meet Us Online at the 3rd International Electronic Conference on Biomedicines, 12–15 May 2025
Conference: 3rd International Electronic Conference on Biomedicines
Time: 12–15 May 2025, CEST, Online
Website: https://sciforum.net/event/ECB2025
We cordially invite you to attend the above event organized by the MDPI journal Biomedicines (ISSN: 2227-9059; Impact Factor: 3.9). The conference will take place virtually on 12–15 May 2025, CEST.
Conference Chairs:
- Prof. Dr. Felipe Fregni, Harvard Medical School, Boston, MA, USA;
- Prof. Dr. Allan Stensballe, Aalborg University, Aalborg, Denmark;
- Prof. Dr. Georgia Levidou, Paracelsus Medical University, Klinikum Nuremberg, Germany;
- Prof. Dr. Serafino Fazio, Federico II University School of Medicine, Naples, Italy.
The Topics of Interest:
S1. Insulin resistance or hyperinsulinemia;
S2. Immunotherapy and adverse effects;
S3. Tumor microenvironment;
S4. Immune system, tumor immunology, and autoimmune disease;
S5. Biomedicine in cardiovascular diseases;
S6. Diabetes, obesity and metabolic diseases;
S7. Gene therapy and gene editing;
S8. Rare diseases;
S9. Molecular mechanisms of neurodegeneration.
Important Dates:
Deadline for abstract submission: 19 January 2025;
Notification of acceptance: 19 February 2025;
Deadline for free registration: 8 May 2025.
Submit your abstract here.
Register for the conference here.
For any inquiries regarding the event, please contact [email protected]. We look forward to seeing you at ECB2025.
